BiotechTube
Home/Vitarka Therapeutics/Agnes Szafranek
AS

Agnes Szafranek

Head of R&D Operations

Vitarka Therapeutics

Therapeutic Areas

Oncology

Vitarka Therapeutics Pipeline

DrugIndicationPhase
EndoPore PlatformLate-stage cancersPre-clinical

Leadership Team at Vitarka Therapeutics

VT
Vineeta Tripathi
CEO
JB
John Beadle
Chairman
TH
Tim Hammonds
CSO
JF
Jim Faulkner
Non-Executive Director
MS
Mayer Schreiber
Investor Director
SC
Stephen Chambers
Board Observer
View full Vitarka Therapeutics profile